B2B software-as-a-service platform that offers 100% DNA analysis solutions for the healthcare and pharmaceutical sectors
Lucid Genomics has raised €1.3M across 1 funding round from 4 investors, most recently a round in Sep 2024. Based in Berlin, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-09-03 | Other | €1.3M |
| another.vc,BIF Partners,Caesar Ventures,MPF Accelerator Program |
| View deal → |
